No photo of David Grimwade

David Grimwade


  • 18419

Personal profile

Research interests

I am interested in the molecular mechanisms underlying the pathogenesis of acute promyelocytic leukaemia (APL), which is one of the commonest forms of acute myeloid leukaemia (AML). APL is characterised by the t(15;17)(q22;q21) chromosomal translocation which fuses the genes encoding PML and Retinoic Acid Receptor Alpha (RARA). APL is of particular interest, being the first form of leukaemia in which therapies (ie all trans retinoic acid (ATRA) and arsenic trioxide) that specifically target the underlying molecular lesion, and which have led to dramatic improvements in outcome of this disease, were introduced into clinical practice.

My research focuses particularly upon characterizing the mechanisms underlying formation of the t(15;17) chromosomal translocation which represents a critical step in leukaemogenesis, defining the progenitors in which this occurs, and the role of deregulation of the PML protein in leukaemic transformation. The laboratory also acts as the National Reference Centre for Molecular Diagnosis of APL, providing a minimal residual disease (MRD) monitoring service to direct patient treatment.

Research interests (short)

Pathogenesis and treatment of acute promyelocytic leukaemia

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being


Dive into the research topics where David Grimwade is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or